Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Jun 24, 2026 (4 months ago)

Bortezomib for Injection 3.5mg/Vial

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Sterility Assurance

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873. NDC: 70069-0836-01

Affected NDC 70069-0836-01

Compare with the code on your package — it is the most precise check available.

Drug: Bortezomib

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Bortezomib
NDC 70069-0836
3.5 mg/3.5mL Injection, Powder, Lyophilized, for Solution
Intravenous|subcutaneous
Somerset Therapeutics LLC Rx
Recalling firm
Reliance Life Sciences Private Limited
Origin
N/A, India
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0673-2026 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Bortezomib recalls

See all
Class III · Low risk

Bortezomib

Failed stability specifications

Terminated Stability / shelf life Dr. Reddy's Laboratories, Inc. NDC 43598-865-60 D-0577-2022
Class II · Moderate risk

VELCADE (bortezomib)

Defective Container: Confirmed reports of loose vial crimps.

Terminated Packaging defect Millennium Pharmaceuticals Inc. NDC 63020-0049-01 D-0425-2018

Other recalls by Reliance Life Sciences Private Limited

All 2026 recalls